These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28195838)

  • 1. The Use of Zonisamide for the Treatment of Psychiatric Disorders: A Systematic Review.
    Buoli M; Grassi S; Ciappolino V; Serati M; Altamura AC
    Clin Neuropharmacol; 2017; 40(2):85-92. PubMed ID: 28195838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial.
    McElroy SL; Kotwal R; Guerdjikova AI; Welge JA; Nelson EB; Lake KA; D'Alessio DA; Keck PE; Hudson JI
    J Clin Psychiatry; 2006 Dec; 67(12):1897-906. PubMed ID: 17194267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is adjunctive open-label zonisamide effective for bipolar disorder?
    Ghaemi SN; Shirzadi AA; Klugman J; Berv DA; Pardo TB; Filkowski MM
    J Affect Disord; 2008 Jan; 105(1-3):311-4. PubMed ID: 17586053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zonisamide: review of pharmacology, clinical efficacy, tolerability, and safety.
    Kothare SV; Kaleyias J
    Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):493-506. PubMed ID: 18433351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial.
    McElroy SL; Kotwal R; Hudson JI; Nelson EB; Keck PE
    J Clin Psychiatry; 2004 Jan; 65(1):50-6. PubMed ID: 14744168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zonisamide in the treatment of bulimia nervosa: an open-label, pilot, prospective study.
    Guerdjikova AI; Blom TJ; Martens BE; Keck PE; McElroy SL
    Int J Eat Disord; 2013 Nov; 46(7):747-50. PubMed ID: 23893331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric adverse effects of zonisamide in patients with epilepsy and mental disorder comorbidities.
    Cavanna AE; Seri S
    Epilepsy Behav; 2013 Nov; 29(2):281-4. PubMed ID: 24070880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zonisamide in pediatric epilepsy: review of the Japanese experience.
    Glauser TA; Pellock JM
    J Child Neurol; 2002 Feb; 17(2):87-96. PubMed ID: 11952083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania.
    Kanba S; Yagi G; Kamijima K; Suzuki T; Tajima O; Otaki J; Arata E; Koshikawa H; Nibuya M; Kinoshita N
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):707-15. PubMed ID: 7938561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute treatment of bipolar depression with adjunctive zonisamide: a retrospective chart review.
    Baldassano CF; Ghaemi SN; Chang A; Lyman A; Lipari M
    Bipolar Disord; 2004 Oct; 6(5):432-4. PubMed ID: 15383137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zonisamide-induced psychosis in a patient with bipolar disorder and narcolepsy.
    Platt JE; Opler LA; Platt EM
    Am J Ther; 2014; 21(3):e88-9. PubMed ID: 22713527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zonisamide: review of its use in epilepsy therapy.
    Zareba G
    Drugs Today (Barc); 2005 Sep; 41(9):589-97. PubMed ID: 16341290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy and safety of monotherapy and adjunctive therapy with zonisamide.
    Tosches WA; Tisdell J
    Epilepsy Behav; 2006 May; 8(3):522-6. PubMed ID: 16542880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of zonisamide in patients with chronic pain or epilepsy refractory to other treatments: a retrospective, open label, uncontrolled study in a VA hospital.
    Hasegawa H
    Curr Med Res Opin; 2004 May; 20(5):577-80. PubMed ID: 15140322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy.
    Wroe SJ; Yeates AB; Marshall A
    Acta Neurol Scand; 2008 Aug; 118(2):87-93. PubMed ID: 18547272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, placebo-controlled study of zonisamide to prevent olanzapine-associated weight gain.
    McElroy SL; Winstanley E; Mori N; Martens B; McCoy J; Moeller D; Guerdjikova AI; Keck PE
    J Clin Psychopharmacol; 2012 Apr; 32(2):165-72. PubMed ID: 22367654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zonisamide for weight loss in obese adults: a randomized controlled trial.
    Gadde KM; Franciscy DM; Wagner HR; Krishnan KR
    JAMA; 2003 Apr; 289(14):1820-5. PubMed ID: 12684361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures.
    Baulac M; Leppik IE
    Epilepsy Res; 2007 Jul; 75(2-3):75-83. PubMed ID: 17553670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical prescribing and long-term efficacy and safety of zonisamide.
    Leppik IE
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S17-24. PubMed ID: 16406743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zonisamide monotherapy for epilepsy in children and young adults.
    Wilfong AA
    Pediatr Neurol; 2005 Feb; 32(2):77-80. PubMed ID: 15664764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.